Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.
2.

Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.

Bendrik C, Robertson J, Gauldie J, Dabrosin C.

Cancer Res. 2008 May 1;68(9):3405-12. doi: 10.1158/0008-5472.CAN-08-0295.

3.

Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.

Nilsson UW, Jönsson JA, Dabrosin C.

Exp Cell Res. 2009 Jan 1;315(1):1-9. doi: 10.1016/j.yexcr.2008.10.015. Epub 2008 Oct 28.

PMID:
18996114
4.

MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells.

Nilsson UW, Garvin S, Dabrosin C.

Breast Cancer Res Treat. 2007 May;102(3):253-61. Epub 2006 Oct 10.

PMID:
17031577
5.

Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer.

Bendrik C, Karlsson L, Dabrosin C.

Cancer Lett. 2010 Jun 1;292(1):32-40. doi: 10.1016/j.canlet.2009.11.002. Epub 2009 Nov 26.

PMID:
19944523
6.

Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.

Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P, Yan L.

Cancer Res. 2005 Apr 15;65(8):3193-9.

7.
8.

Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13.

Nyberg P, Heikkilä P, Sorsa T, Luostarinen J, Heljasvaara R, Stenman UH, Pihlajaniemi T, Salo T.

J Biol Chem. 2003 Jun 20;278(25):22404-11. Epub 2003 Apr 10.

9.

Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.

Lindahl G, Saarinen N, Abrahamsson A, Dabrosin C.

Cancer Res. 2011 Jan 1;71(1):51-60. doi: 10.1158/0008-5472.CAN-10-2289. Epub 2010 Nov 19.

10.
12.

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC.

BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20.

13.
14.

Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.

Williams RN, Parsons SL, Morris TM, Rowlands BJ, Watson SA.

Eur J Surg Oncol. 2005 Nov;31(9):1042-50. Epub 2005 Jul 1.

PMID:
15993560
15.

Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.

Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond HP, Wang JH.

Ann Surg Oncol. 2009 May;16(5):1403-11. doi: 10.1245/s10434-009-0343-6. Epub 2009 Mar 5.

PMID:
19263173
16.

Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer.

Leifler KS, Svensson S, Abrahamsson A, Bendrik C, Robertson J, Gauldie J, Olsson AK, Dabrosin C.

J Immunol. 2013 Apr 15;190(8):4420-30. doi: 10.4049/jimmunol.1202610. Epub 2013 Mar 15.

17.

The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer.

Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N.

J Pathol. 2001 May;194(1):43-50.

PMID:
11329140
18.
19.
20.

[Comparison of the effect of rh-endostatin on intratumoral and myocardial micrangium in mice].

Zhang CC, Li K, Wei XY, Chen C, Yuan J, Wang J.

Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):415-20. Chinese.

PMID:
21875480

Supplemental Content

Support Center